돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1294629생성일: 2026년 10월 25일

Stannous chloride dihydrate → 1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-ethylbenzoyl]-piperidine

https://huagongshe.com/reaction/1294629

반응식

참여 물질

역할이름HCID투입량
반응물Stannous chloride dihydrateHCID 61436—
반응물2,1,3-Benzothiadiazole, 4-chlorosulfonyl-HCID 2735459—
반응물(4-Ethyl-2-nitro-phenyl)-piperidin-1-yl-methanoneHCID 16090717—
반응물2-Amino-4-ethyl-phenyl-piperidin-1-yl-methanoneHCID 16090737—
생성물1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-ethylbenzoyl]-piperidineHCID 11396307—

반응 단계

To a stirred solution of 2-nitro-4-vinylbenzoic acid piperidine amide (100 mg, 0.39 mmol) in methanol (15 mL) was added Pd on carbon (10 wt %, 25 mg). The reaction mixture was maintained under ˜1 atm H2 and stirred for 12 h. The mixture was filtered through diatomaceous earth and concentrated in vacuo to yield (4-ethyl-2-nitro-phenyl)-piperidin-1-yl-methanone, which was subsequently reduced to (2-amino-4-ethyl-phenyl)-piperidin-1-yl-methanone with SnCl2.2H2O as described in EXAMPLE 5. The title compound was prepared from the aniline (90 mg, 0.39 mmol) and 4-chlorosulfonyl-2,1,3-benzothiadiazole (181 mg, 0.78 mmol), and purified as described in EXAMPLE 15 TLC (silica gel, 3:1 EtOAc/hexanes): Rf=0.32. MS (ESI): m/z 431 [M+H]+, 453 [M+Na]+. HPLC (reversed-phase): RT=9.52 min (single peak). 1H NMR (400 MHz, CDCl3): (rotameric broadening) 8.95 (s, 1H), 8.21 (m, 2H), 7.65 (dd, J=8.8, 7 Hz, 1H), 7.47 (d, J=1.3 Hz, 1H), 6.95 (d, J=7.8 Hz, 1H), 6.85 (dd, J=7.9, 1.6 Hz, 1H), 3.14 (bs, 4H), 2.60 (m, 2H), 1.61 (m, 2H), 1.43 (bs, 4H), 1.17 (t, J=7.6 Hz, 3H). Elemental analysis: calculated for C20H22N4O3S2, C, 55.79; H, 5.15; N, 13.01; found C, 55.44; H, 5.50; N, 12.62.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07241759B2
출처 데이터셋uspto-grants-2007_07
ORD IDord-3461e8cc8be749c8bd476112515c0ed7
출처 메모uspto-grants-2007_07